Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hikma Pharmaceuticals (HIK) Share Price

Price 1,627.00p on 30-09-2026 at 10:46:15
Change 18.00p 1.12%
Buy 1,628.00p
Sell 1,626.00p
Last Trade: Buy 59.00 at 1,627.00p
Day's Volume: 140,134
Last Close: 1,609.00p
Open: 1,611.00p
ISIN: GB00B0LCW083
Day's Range 1,611.00p - 1,633.00p
52wk Range: 1,187.00p - 1,865.00p
Market Capitalisation: £3.37b
VWAP: 1,616.73832p
Shares in Issue: 206.97m

Hikma Pharmaceuticals (HIK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 59 1,627.00p Automatic Execution
11:46:15 - 30-Sep-26
Buy* 337 1,627.00p Automatic Execution
11:46:15 - 30-Sep-26
Buy* 63 1,627.00p Automatic Execution
11:46:15 - 30-Sep-26
Sell* 61 1,627.00p Automatic Execution
11:45:22 - 30-Sep-26
Buy* 98 1,627.00p Automatic Execution
11:45:15 - 30-Sep-26
Buy* 136 1,627.00p Automatic Execution
11:45:15 - 30-Sep-26
Buy* 102 1,627.00p Automatic Execution
11:45:15 - 30-Sep-26
Sell* 55 1,627.00p Automatic Execution
11:45:15 - 30-Sep-26
Sell* 53 1,627.00p Automatic Execution
11:42:09 - 30-Sep-26
Sell* 26 1,627.00p Automatic Execution
11:42:09 - 30-Sep-26
See more Hikma Pharmaceuticals trades

Hikma Pharmaceuticals (HIK) Share Price History

Time period:
to
Date Open High Low Close Volume
29th Sep 2026 (Tue) 1,600.00 1,614.00 1,586.00 1,609.00 447,404
28th Sep 2026 (Mon) 1,593.00 1,606.00 1,591.00 1,592.00 409,317
25th Sep 2026 (Fri) 1,589.00 1,619.00 1,578.00 1,590.00 264,731
24th Sep 2026 (Thu) 1,583.00 1,631.00 1,583.00 1,625.00 391,599
23rd Sep 2026 (Wed) 1,589.00 1,600.00 1,577.00 1,595.00 386,898
22nd Sep 2026 (Tue) 1,600.00 1,620.00 1,597.00 1,606.00 376,834
21st Sep 2026 (Mon) 1,630.00 1,630.00 1,585.00 1,611.00 355,872
18th Sep 2026 (Fri) 1,585.00 1,619.00 1,580.00 1,600.00 1,082,972
17th Sep 2026 (Thu) 1,571.00 1,596.00 1,570.00 1,596.00 650,623
16th Sep 2026 (Wed) 1,560.00 1,567.00 1,555.00 1,565.00 326,984
15th Sep 2026 (Tue) 1,551.00 1,566.00 1,538.00 1,557.00 280,289
14th Sep 2026 (Mon) 1,518.00 1,564.00 1,518.00 1,544.00 1,003,181
11th Sep 2026 (Fri) 1,497.00 1,540.00 1,486.00 1,531.00 382,738
10th Sep 2026 (Thu) 1,569.00 1,569.00 1,488.00 1,498.00 639,474
9th Sep 2026 (Wed) 1,591.00 1,591.00 1,525.00 1,535.00 571,176
8th Sep 2026 (Tue) 1,616.00 1,637.00 1,596.00 1,596.00 504,064
7th Sep 2026 (Mon) 1,580.00 1,600.00 1,571.00 1,600.00 375,532
4th Sep 2026 (Fri) 1,600.00 1,604.00 1,585.00 1,593.00 365,401
3rd Sep 2026 (Thu) 1,620.00 1,627.00 1,597.00 1,605.00 302,087
2nd Sep 2026 (Wed) 1,615.00 1,630.00 1,600.00 1,615.00 438,673
1st Sep 2026 (Tue) 1,623.00 1,633.00 1,607.00 1,615.00 516,929
31st Aug 2026 (Mon) 1,616.00 1,616.00 1,616.00 1,616.00 0
See more Hikma Pharmaceuticals price history

Hikma Pharmaceuticals (HIK) Regulatory News

Date Source Headline
24th Sep 2026 7:00 am RNS Hikma appoints Rebecca Hall as CFO
22nd Sep 2026 12:00 pm RNS Hikma R&D Investor Spotlight Series
22nd Sep 2026 9:32 am RNS Director/PDMR Shareholding
2nd Sep 2026 1:45 pm RNS Holding(s) in Company
1st Sep 2026 4:13 pm RNS Total Voting Rights
28th Aug 2026 7:00 am RNS Transaction in Own Shares
24th Aug 2026 3:03 pm RNS Director/PDMR Shareholding
24th Aug 2026 10:54 am RNS Transaction in Own Shares
17th Aug 2026 3:24 pm RNS Holding(s) in Company
17th Aug 2026 2:57 pm RNS Holding(s) in Company
See more Hikma Pharmaceuticals regulatory news

Hikma Pharmaceuticals (HIK) Share News

IN BRIEF: Hikma Pharmaceuticals appoints ViiV's Rebecca Hall as CFO

24th Sep 2026 09:10

Hikma Pharmaceuticals PLC - London-based pharmaceutical maker - Appoints Rebecca Hall as chief financial officer, effective from a to-be-announced date in the first quarter of 2027, which Hikma will confirm "in due course." Hall joins Hikma from ViiV Healthcare Ltd, a specialist HIV pharmaceutical company majority owned by GSK PLC, with pharma firm Shionogi & Co Ltd as a shareholder. At ViiV Healthcare, Hall is senior vice president and CFO, responsible for finance, supply chain and business development. Hikma Chair Victoria Hull said: "Becky's appointment is a further step in broadening the expertise we have across both the executive team and the board, positioning us well for long-term sustainable growth." Read More

UK dividends calendar - next 7 days

10th Sep 2026 14:33

Read More

WINNERS & LOSERS: Oil up, Dunelm down, Computacenter rises then falls

8th Sep 2026 10:24

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Tuesday. Read More

LONDON BROKER RATINGS: Jefferies raises Autotrader and Rightmove

8th Sep 2026 09:08

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Citigroup says 'buy' Next, UBS raises Drax

25th Aug 2026 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

See more Hikma Pharmaceuticals news
FTSE 100 Latest
Value10,648.57
Change11.86

Login to your account

Forgot Password?

Not Registered